Literature DB >> 17954243

Measurement of autotaxin/lysophospholipase D activity.

Andrew J Morris1, Susan S Smyth.   

Abstract

Lysophosphatidic acid (LPA) is a bioactive lipid mediator present in the blood and other biological fluids at physiologically relevant concentrations. In the cardiovascular system, studies using in vitro and in vivo experimental models indicate that LPA stimulates platelet activation, differentiation and migration of vascular smooth muscle cells, and changes in vascular tone. A growing body of evidence suggests that aberrant production and actions of LPA could play an important role in atherothrombotic disease. Hydrolysis of lysophospholipids by the secreted plasma protein autotaxin/lysophospholipase D (lysoPLD) is a major mechanism for generation of LPA in the blood. This chapter describes methods for determining the activity of recombinant autotaxin/lysoPLD using radiolabeled and fluorogenic substrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954243     DOI: 10.1016/S0076-6879(07)34005-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  8 in total

1.  Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis.

Authors:  Qi Xia; An-mei Deng; Shan-shan Wu; Min Zheng
Journal:  Acta Pharmacol Sin       Date:  2011-07-18       Impact factor: 6.150

2.  Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.

Authors:  Jian-Min Wu; Yan Xu; Nicholas J Skill; Hongmiao Sheng; Zhenwen Zhao; Menggang Yu; Romil Saxena; Mary A Maluccio
Journal:  Mol Cancer       Date:  2010-03-31       Impact factor: 27.401

Review 3.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

4.  Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.

Authors:  Russell R Braeuer; Maya Zigler; Takafumi Kamiya; Andrey S Dobroff; Li Huang; Woonyoung Choi; David J McConkey; Einav Shoshan; Aaron K Mobley; Renduo Song; Avraham Raz; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

5.  Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.

Authors:  Zehra Pamuklar; Lorenzo Federico; Shuying Liu; Makiko Umezu-Goto; Anping Dong; Manikandan Panchatcharam; Zachary Fulkerson; Zachary Fulerson; Evgeny Berdyshev; Viswanathan Natarajan; Xianjun Fang; Laurens A van Meeteren; Wouter H Moolenaar; Gordon B Mills; Andrew J Morris; Susan S Smyth
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

6.  5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.

Authors:  Wenjuan Su; Oladapo Yeku; Srinivas Olepu; Alyssa Genna; Jae-Sook Park; Hongmei Ren; Guangwei Du; Michael H Gelb; Andrew J Morris; Michael A Frohman
Journal:  Mol Pharmacol       Date:  2008-12-08       Impact factor: 4.436

7.  Up-regulation of the inwardly rectifying K⁺ channel Kir2.1 (KCNJ2) by protein kinase B (PKB/Akt) and PIKfyve.

Authors:  Carlos Munoz; Ahmad Almilaji; Iwan Setiawan; Michael Föller; Florian Lang
Journal:  J Membr Biol       Date:  2012-11-28       Impact factor: 1.843

8.  Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.

Authors:  Yutong Zhao; Jiankun Tong; Donghong He; Srikanth Pendyala; Berdyshev Evgeny; Jerold Chun; Anne I Sperling; Viswanathan Natarajan
Journal:  Respir Res       Date:  2009-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.